Cargando…
Human Serum Albumin in the Presence of AGuIX Nanoagents: Structure Stabilisation without Direct Interaction
The gadolinium-based nanoagent named AGuIX(®) is a unique radiosensitizer and contrast agent which improves the performance of radiotherapy and medical imaging. Currently tested in clinical trials, AGuIX(®) is administrated to patients via intravenous injection. The presence of nanoparticles in the...
Autores principales: | Yang, Xiaomin, Bolsa-Ferruz, Marta, Marichal, Laurent, Porcel, Erika, Salado-Leza, Daniela, Lux, François, Tillement, Olivier, Renault, Jean-Philippe, Pin, Serge, Wien, Frank, Lacombe, Sandrine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369717/ https://www.ncbi.nlm.nih.gov/pubmed/32630060 http://dx.doi.org/10.3390/ijms21134673 |
Ejemplares similares
-
Functionalization of theranostic AGuIX® nanoparticles for PET/MRI/optical imaging
por: Thakare, Vivek, et al.
Publicado: (2019) -
EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: From animal to human with theranostic AGuIX nanoparticles
por: Bort, Guillaume, et al.
Publicado: (2020) -
Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma
por: Thomas, Eloïse, et al.
Publicado: (2017) -
Green One-Step Synthesis of Medical Nanoagents for Advanced Radiation Therapy
por: Salado-Leza, Daniela, et al.
Publicado: (2020) -
Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX(®)-Design Nanoparticles
por: Lerouge, Lucie, et al.
Publicado: (2023)